Effectiveness of a Home-Based Rehabilitation Program in Stroke Survivors Using the Euleria Home® Device
Launched by UNIVERSITA DI VERONA · May 5, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the effectiveness of a home-based rehabilitation program for stroke survivors using a special device called the Euleria Home®. The goal is to see if this new telemedicine approach can help patients recover just as well as traditional rehabilitation that takes place in person. Researchers will compare the improvements in movement, thinking, and language skills between those using the home device and those receiving standard outpatient therapy.
To be eligible for the trial, participants should be at least 18 years old and have had their first ischemic stroke verified by a brain scan. They should also have some difficulties with speech or thinking, and need a reliable internet connection to use the telerehabilitation system. Participants and their caregivers must be willing to learn how to use the technology and provide written consent to join the study. This trial is currently recruiting participants, and it aims to help find effective rehabilitation methods that can be done from home, making recovery more accessible for stroke survivors.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age over 18 years.
- • First diagnosis of ischemic stroke, documented radiologically via CT or MRI scans, corresponding to ICD-9-CM codes 433 and 434 .
- • Presence of aphasia, as assessed by the Aachener Aphasia Test (AAT), and/or cognitive deficits identified through the Oxford Cognitive Screen (OCS).
- • Availability of an ADSL or higher-speed internet connection at the patient's residence.
- • Ability of the patient and/or caregiver to understand and utilize the telerehabilitation system.
- • Provision of written informed consent.
- Exclusion Criteria:
- • Contemporanea partecipazione ad altri studi clinici;
- • Decadimento cognitivo
- • Deformità ossee come conseguenza di precedenti eventi traumatici ai 4 arti;
- • Contratture fisse ai 4 arti valutate come 4/4 alla scala di Ashworth modificata (MAS)
- • Altre patologie neurologiche e ortopediche in grado di interferire con lo studio.
About Universita Di Verona
The Università di Verona is a prestigious academic institution in Italy, renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university collaborates with various healthcare professionals and institutions to explore new therapies and improve patient outcomes. Its research initiatives are driven by a multidisciplinary approach, leveraging cutting-edge technology and methodologies. The Università di Verona aims to contribute significantly to the scientific community and public health by fostering rigorous clinical studies that address pressing medical challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Verona, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported